In vitro dexamethasone treatment does not induce alternative ATM transcripts in cells from Ataxia-Telangiectasia patients.

Scientific Reports
Elisa PozziAlfredo Brusco

Abstract

Short term treatment with low doses of glucocorticoid analogues has been shown to ameliorate neurological symptoms in Ataxia-Telangiectasia (A-T), a rare autosomal recessive multisystem disease that mainly affects the cerebellum, immune system, and lungs. Molecular mechanisms underlying this clinical observation are unclear. We aimed at evaluating the effect of dexamethasone on the induction of alternative ATM transcripts (ATMdexa1). We showed that dexamethasone cannot induce an alternative ATM transcript in control and A-T lymphoblasts and primary fibroblasts, or in an ATM-knockout HeLa cell line. We also demonstrated that some of the reported readouts associated with ATMdexa1 are due to cellular artifacts and the direct induction of γH2AX by dexamethasone via DNA-PK. Finally, we suggest caution in interpreting dexamethasone effects in vitro for the results to be translated into a rational use of the drug in A-T patients.

References

Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·N ZhangM F Lavin
Jan 6, 1999·Seminars in Pediatric Neurology·T O Crawford
Oct 24, 2001·The Journal of Biological Chemistry·I M Ward, J Chen
Jan 27, 2004·The Journal of Biological Chemistry·Irene M WardJunjie Chen
Nov 29, 2007·Pediatric Pulmonology·Sharon McGrath-MorrowHoward M Lederman
Jan 16, 2009·Nature Reviews. Neuroscience·Peter J McKinnon
May 23, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Richard A Gatti, Susan Perlman
May 29, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·I RussoC Pignata
Feb 13, 2010·Epigenetics : Official Journal of the DNA Methylation Society·Li-Jeen MahTom C Karagiannis
Jun 29, 2010·FEBS Letters·Frederick A Derheimer, Michael B Kastan
Sep 16, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T BroccolettiC Pignata
Oct 23, 2010·Science·Zhi GuoTanya T Paull
Nov 26, 2010·Nucleic Acids Research·Arnon PazRon Shamir
Apr 26, 2011·Cellular Signalling·Xianming KongJun Mi
Dec 2, 2011·Neoplasia : an International Journal for Oncology Research·Euan A StronachHani Gabra
Jul 6, 2012·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Mario QuarantelliClaudio Pignata
Aug 29, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Raffaella ZannolliLuciana Chessa
Nov 6, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·G GiardinoC Pignata
Mar 15, 2013·Nature Reviews. Molecular Cell Biology·Yosef Shiloh, Yael Ziv
Jul 22, 2014·Clinical Genetics·A M R TaylorP J Byrd
Jan 17, 2015·The International Journal of Biochemistry & Cell Biology·Ji Hoon YuHyeyoung Kim
Apr 18, 2015·Neurology. Neuroimmunology and Neuroinflammation·Vincenzo LeuzziMauro Magnani
Sep 8, 2015·Nature Cell Biology·Jiangwei ZhangCheryl Lyn Walker
Jul 27, 2017·Molecular and Cellular Biochemistry·Michele MenottaMauro Magnani
Mar 1, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E CirilloC Pignata

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
biopsies

Clinical Trials Mentioned

NCT02770807

Software Mentioned

GraphPad
Graph Pad Prism
GraphPad Statistics
Image Lab

Related Concepts

Related Feeds

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.